Top

Journal of Diabetes & Metabolic Disorders

Published in:

Open Access 01-12-2017 | Review article

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic

Authors: Niloofar Peykari, Hassan Hashemi, Rasoul Dinarvand, Mohammad Haji-Aghajani, Reza Malekzadeh, Ali Sadrolsadat, Ali Akbar Sayyari, Mohsen Asadi-lari, Alireza Delavari, Farshad Farzadfar, Aliakbar Haghdoost, Ramin Heshmat, Hamidreza Jamshidi, Naser Kalantari, Ahmad Koosha, Amirhossein Takian, Bagher Larijani

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2017

Abstract

Emerging Non-communicable diseases burden move United Nation to call for 25% reduction by 2025 in premature mortality from non-communicable diseases (NCDs). The World Health Organization (WHO) developed global action plan for prevention and control NCDs, but the countries’ contexts, priorities, and health care system might be different. Therefore, WHO expects from countries to meet national commitments to achieve the 25 by 25 goal through adapted targets and action plan.

In this regards, sustainable high-level political statement plays a key role in rules and regulation support, and multi-sectoral collaborations to NCDs’ prevention and control by considering the sustainable development goals and universal health coverage factors.

Therefore, Iran established the national authority’s structure as Iranian Non Communicable Diseases Committee (INCDC) and developed NCDs’ national action plan through multi-sectoral approach and collaboration researchers and policy makers. Translation Iran’s expertise could be benefit to mobilizing leadership in other countries for practical action to save the millions of peoples.

Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva, World Health Organization; 2013. Available from: who.int/nmh/events/ncd_action_plan/en/. [Cited 2016 Sep 19].

Sustainable Development Goals. New York, The United Nations; Available from: The: http://www.sustainabledevelopment.un.org/?menu=1300. [Cited 2016 Oct 2].

Alwan A. The world health assembly responds to the global challenge of noncommunicable diseases. East Mediterr Health J. 2013;19(6):511–2.PubMed

UN General Assembly. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases. A/66/L.1. New York, The United Nations; 2011. Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/66/L.1. [Cited 2016 Oct 2].

Global status report on NCDs 2014. Geneva, World Health Organization; 2014. www.who.int/nmh/publications/ncd-status-report-2014/en/. [Cited 2016 Oct 2].

David J, Hunter KSR. Noncommunicable diseases. N Engl J Med. 2013;369:1336–43.CrossRef

Haagsma JA, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany EC, et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the global burden of disease study 2013. Inj Prev. 2016;22(1):3–18.CrossRefPubMed

Non-communicable Diseases (NCD) Country Profiles. Geneva, World Health Organization; 2014. Available from: http://who.int/nmh/countries/irn_en.pdf?ua=1. [Cited 2016 Sep 3].

NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef

10.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.CrossRef

11.

Asadi-Lari M, Sayyari A, Akbari M, Gray D. Public health improvement in Iran—lessons from the last 20 years. Public Health. 2004;118(6):395–402.CrossRefPubMed

12.

Global burden of Diseases. Washington, Institute of Health Metric and Evaluation; 2014, Available from: http://vizhub.healthdata.org/gbd-compare/. [Cited 2016 Sep 3].

13.

Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.CrossRef

14.

Richards NC, Gouda HN, Durham J, Rampatige R, Rodney A, Whittaker M. Disability, noncommunicable disease and health information. Bull World Health Organ. 2016;94(3):230–2.CrossRefPubMedPubMedCentral

15.

Peykari N, Djalalinia S, Qorbani M, Sobhani S, Farzadfar F, Larijani B. Socioeconomic inequalities and diabetes: a systematic review from Iran. J Diabetes Metab Disord. 2015;14:8.CrossRefPubMedPubMedCentral

16.

Ferguson L, Tarantola D, Hoffmann M, Gruskin S. Non-communicable diseases and human rights: Global synergies, gaps and opportunities. Global Public Health. 2016;1–28. Available at: http://www.tandfonline.com/doi/abs/10.1080/17441692.2016.1158847. [ Cited in 25 Dec 2016].

17.

Low WY, Lee YK, Samy AL. Non-communicable diseases in the Asia-Pacific region: prevalence, risk factors and community-based prevention. Int J Occup Med Environ Health. 2015;28(1):20–6.PubMed

18.

Sanghera D. Emerging epidemic of non-communicable diseases (NCDs) in south Asia: opportunities for prevention. J Diab Metab. 2016;7(647):2.

19.

Mendis S, Davis S, Norrving B. Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015;46(5):e121–2.CrossRefPubMed

20.

Bowman S, Unwin N, Critchley J, Capewell S, Husseini A, Maziak W, et al. Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop. Bull World Health Organ. 2012;90(11):847–53.CrossRefPubMedPubMedCentral

21.

Rajabi F, Esmailzadeh H, Rostamigooran N, Majdzadeh R. What must be the pillars of Iran’s health system in 2025? values and principles of health system reform plan. Iran J Public Health. 2013;42(2):197.PubMedPubMedCentral

22.

Scaling up action against non-communicable diseases:how much will it cost? Geneva: World Health Organization, 2011; Available from: www.who.int/nmh/publications/cost_of_inaction/en/. [Cited 2016 Sep 25].

23.

Moghaddam AV, Damari B, Alikhani S, Salarianzedeh M, Rostamigooran N, Delavari A, et al. Health in the 5th 5-years development plan of Iran: main challenges, general policies and strategies. Iran J Public Health. 2013;42(Supple1):42–9.

24.

Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378(9789):449–55.CrossRefPubMed

25.

Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, et al. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet. 2013;381(9866):575–84.CrossRefPubMed

26.

Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, et al. NASBOD 2013: design, definitions, and metrics. Arch Iran Med. 2014;17(1):7–15.PubMed

27.

Ghasemian A, Ataie-Jafari A, Khatibzadeh S, Mirarefin M, Jafari L, Nejatinamini S, et al. National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990–2013; study protocol. Arch Iran Med. 2014;17(3):146–58.PubMed

28.

Peykari N, Sepanlou SG, Djalalinia S, Kasaeian A, Parsaeian M, Ahmadvand A, et al. National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990–2013, study protocol. Arch Iran Med. 2014;17(1):54–61.PubMed

29.

Peykari N, Saeedi MS, Djalalinia S, Kasaeian A, Sheidaei A, Mansouri A, et al. High fasting plasma glucose mortality effect: a comparative risk assessment in 25–64 years old Iranian population. Int J Prev Med. 2016;7:75.CrossRefPubMedPubMedCentral

30.

Prevalence of insufficient phisycal activity. Geneva: World Health Organization; 2010. Available from: http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/physical_inactivity/atlas.html?indicator=i1&date=Female. [Cited 2016 Sep 25].

31.

Prevalence of insufficient phisycal activity. Geneva: World Health Organization; 2010. Available from:http://gamapserver.who.int/gho/interactive_charts/ncd/risk_factors/physical_inactivity/atlas.html?indicator=i1&date=Male. [Cited 2016 Sep 25].

32.

Beran D, Perrin C, Billo N, Yudkin JS. Improving global access to medicines for non-communicable diseases. Lancet Glob Health. 2014;2(10):e561–2.CrossRefPubMed

33.

Schmidt H, Gostin LO, Emanuel EJ. Public health, universal health coverage, and sustainable development goals: can they coexist? Lancet. 2015;386(9996):928–30.CrossRefPubMed

34.

Hashemi H, Larijani B, Sayari AK, Malekzadeh R, Dinarvand R, Aghajani M, et al. Iranian Non Communicable Diseases Committee (INCDC), Ministry of Heath and Medical Education. National Action Plan for Prevention and Control of NCDs and the Related Risk Factors in the Islamic Republic of Iran, 2015 to 2025. Tehran, Iran; 2015. Available from: http://incdc.behdasht.gov.ir/uploads/sanadmelli_en.pdf. [cited 2016 May 8].

35.

Kutzin J. Health financing for universal coverage and health system performance: concepts and implications for policy. Bull World Health Organ. 2013;91(8):602–11.CrossRefPubMedPubMedCentral

36.

Magnusson RS, Patterson D. The role of law and governance reform in the global response to non-communicable diseases. Global Health. 2014;10:44.CrossRefPubMedPubMedCentral

37.

Mehrdad R. Health system in Iran. JMAJ. 2009;52(1):69–73.

38.

Marandi SA. The integration of medical education and health care system in the Islamic Republic of Iran: a historical overview. J Med Educ. 2001;1(1):8–10.

39.

Hashemi H, Larijani B, Sayari AK, Malekzadeh R, Dinarvand R, Aghajani M, et al. Report on prevention and control of non communicable diseases to celebrate the first anniversary of INCDC establishment. Tehran: Iranian Non-communicable Diseases Committee, Ministry of Heath and Medical Education; 2016.

40.

Mendis S, Chestnov O. Policy reform to realize the commitments of the political declaration on noncommunicable diseases. Br Med Bull. 2013;105:7–27.CrossRefPubMed

41.

Noncommunicable Diseases Progress Monitor 2015. Geneva: World Health Organization; Available from: 2015. http://www.who.int/nmh/media/ncd-progress-monitor/en/. [Cited 2016 Oct 2].

42.

Aldehayyat JS, Anchor JR. Strategic planning implementation and creation of value in the firm. Strateg Chang. 2010;19(3–4):163–76.CrossRef

43.

Bolo AZ, Nkirote KC. Bottleneck in the execution of Kenya vision 2030 strategy: an empirical study. PJ Bus Adm Manag. 2012;2(3):505–12.

44.

Maher D, Harries AD, Zachariah R, Enarson D. A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health. 2009;9(1):355.CrossRefPubMedPubMedCentral

45.

Lupafya PC, Mwagomba BL, Hosig K, Maseko LM, Chimbali H. Implementation of policies and strategies for control of noncommunicable diseases in Malawi: challenges and opportunities. Health Educ Behav. 2016;43(1 Suppl):64S–9S.CrossRefPubMed

Title: National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic
Authors: Niloofar Peykari
Hassan Hashemi
Rasoul Dinarvand
Mohammad Haji-Aghajani
Reza Malekzadeh
Ali Sadrolsadat
Ali Akbar Sayyari
Mohsen Asadi-lari
Alireza Delavari
Farshad Farzadfar
Aliakbar Haghdoost
Ramin Heshmat
Hamidreza Jamshidi
Naser Kalantari
Ahmad Koosha
Amirhossein Takian
Bagher Larijani
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2017
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1186/s40200-017-0288-4

Adherence to insulin self administration and associated factors among diabetes mellitus patients at Tikur Anbessa specialized hospital

Open Access
Research article

HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?

Open Access
Research article

Cardiovascular risk assessment by FRS and SCORE in Iranian adult population

Open Access
Research article

Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1α levels in type-1 diabetic rats

Open Access
Research article

Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models

Open Access
Research article

Effect of melatonin versus vitamin D as antioxidant and Hepatoprotective agents in STZ-induced diabetic rats

Open Access
Research article

Keynote webinar | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Please log in to get access to this content